Ptc Therapeutics (PTCT) Gross Margin (2016 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Gross Margin of 94.47% for Q2 2026, up 86.0% year-over-year from 50.79% in Q2 2025, and up 5.3% quarter-over-quarter from 89.72% in Q1 2026.
Powered by 
Analysis
Ptc Therapeutics (PTCT) Gross Margin (2016 - 2026) Analysis & Trends
Ptc Therapeutics' Gross Margin history runs 11 years deep, the most recent figure standing at 94.47% for Q2 2026.
- In Q2 2026, Gross Margin rose 86.0% year-over-year to 94.47%; the TTM figure through Jun 2026 stood at 92.99% (down 409.0% YoY), while the FY2025 annual figure was 97.28%, up 440.0% from the prior year.
- Gross Margin for Q2 2026 stood at 94.47%, up from 89.72% in the prior quarter.
- The five-year high for Gross Margin was 98.91% in Q1 2025, with the low at 89.72% in Q1 2026.
- The 5-year median for Gross Margin is 93.58% (2023), against an average of 93.68%.
- The sharpest annual moves came in 2025 and 2026: Gross Margin surged 592 bps in 2025, then sank 919 bps in 2026.
- Ptc Therapeutics' Gross Margin stood at 93.49% in 2022, then retreated by 3 bps to 90.52% in 2023, then climbed by 2 bps to 92.36% in 2024, then grew by 4 bps to 95.78% in 2025, then dropped by 1 bps to 94.47% in 2026.
- Business Quant data shows PTCT's Gross Margin at 94.47% in Q2 2026, 89.72% in Q1 2026, and 95.78% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 35.86% |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 89.76% |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 76.90% |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 84.20% |
| 10 | Ptc Therapeutics | 5.79 Bn | 3.56 Bn | 340.60 Mn | 94.47% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 94.47% |
| Mar 31, 2026 | 89.72% |
| Dec 31, 2025 | 95.78% |
| Sep 30, 2025 | 92.52% |
| Jun 30, 2025 | 93.62% |
| Mar 31, 2025 | 98.91% |
| Dec 31, 2024 | 92.36% |
| Sep 30, 2024 | 94.49% |
| Jun 30, 2024 | 91.68% |
| Mar 31, 2024 | 92.98% |
| Dec 31, 2023 | 90.52% |
| Sep 30, 2023 | 95.17% |
| Jun 30, 2023 | 94.05% |
| Mar 31, 2023 | 93.58% |
| Dec 31, 2022 | 93.49% |
| Sep 30, 2022 | 93.55% |
| Jun 30, 2022 | 94.18% |
| Mar 31, 2022 | 93.19% |
| Dec 31, 2021 | 94.36% |
| Sep 30, 2021 | 95.29% |